TORONTO, June 5, 2024 /PRNewswire/ -- Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and ...
The acquisition of 3P innovation's RFF Cell enables Dalton to address larger segments of the pharmaceutical market and serve customers with greater global patient populations. TORONTO — Pharmaceutical ...
In line with Dalton's ongoing mission to adopt cutting-edge technology, this strategic investment not only expands the collaboration between the two organisations, but it also enables Toronto-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results